‘i4MDS’ consortium wins prestigious EHA Innovation Grant

In a significant development, the International Integrative Innovative Immunology for Myelodysplastic Neoplasms consortium—known as the ‘i4MDS’— has received an esteemed EHA Innovation Grant.

Do generics of imatinib jeopardize patient safety for the sake of saving money? An experience in Turkish patients.

 

The high cost of tyrosine kinase inhibitors developed for chronic myeloid leukemia is a major concern for the health care payers, especially in countries with restricted resources.

EHA-SWG Scientific Meeting on Mesenchymal Stromal Cells and Tissue Homeostasis

EHA in collaboration with the meeting chairs (W Fibbe & F Dazzi) have decided to postpone this highly anticipated Scientific Meeting to a future date, to be announced.

Uptake of CAR T cell therapy in Europe

Gene (editing) therapy continues to break ground in hematology, showing promising results in tackling severe blood cancers. Yet, its uptake in the European Union is slow, with few patients benefiting from it so far.

Computational Biology Training in Hematology Hall of Fame

Translational Research Training in Hematology Hall of Fame

COVID-19 Expert opinions

Expert opinions for hematologists in COVID-19 crisis
COVID-19, caused by SARS-CoV-2, is expected to be a devastating infection in many patients with hematologic diseases.